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Advanced glycation end products modulate transcriptional regulation
in mesangial cells. Advanced glycation end products (AGEs) stimulate
synthesis of extracellular matrix (ECM) in a receptor-mediated manner on
mesangial cells. In the present study, we examined the transcriptional
regulation of the gene for type IV collagen [(TV)collagenJ, which is one of
the major components of mesangial sclerosis, after stimulation of AGEs
on mesangial cells. The methylation pattern of the promoter/enhancer
region of (IV)collagen gene was similar in AGE-treated and control cells.
AGEs significantly increased the transcriptional activity of the (IV)colla-
gen gene, as measured by transient transfcction assays using the reporter
gene Construct containing (IV)col!agen promoter/enhancer and the chlor-
amphenicol acetyltransferase gene. AGEs also increased smooth muscle
a-actin mRNA levels as well as its transcriptional activity. Nuclear factor
binding of the promoter of (IV)collagen gene was stimulated by AGEs.
Furthermore, AGEs dramatically decreased the mRNA levels of (IV)col-
lagen promoter binding protein (MSW), a larger subunit of DNA repli-
cation complex, APi. These results suggest that AGEs increase expression
of (IV)collagen gene by modulating the levels of promoter binding
proteins. These transcriptional events may play a critical role in ECM
accumulation in response to AGEs.
Advanced glycation end products (AGEs) are a complex mix-
ture of adducts that have been recognized as a brown fluorescent
material. They form cross-links between proteins by nonenzymatic
reactions between glucose and amino groups of proteins. AGEs
play an important role in biological and pathophysiological re-
sponses of disease and normal growth, including diabetic compli-
cations and the aging process [1, 21. Since specific receptors for
AGEs are found in various cells such as endothelial cells, macro-
phages, fibroblasts and mesangial cells, the responses to AGEs are
thought to be mediated by specific receptors [3, 4]. These effects
are mediated by some cytokines or growth factors (such as tumor
necrosis factor a, interleukin-i, platelet-derived growth factor,
insulin-like growth factor-I); however, the precise mechanism of
the responses to AGEs is still not clear [5, 6].
In diabetic nephropathy, one of the major causes of end-stage
kidney disease in Japan and the United States, there is accumu-
lating evidence that AGEs have a pathogenic role in the devel-
opment of diabetic glomerulopathy. The characteristic glomerular
findings of diabetic nephropathy are both mesangial cell prolifer-
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ation and accumulation of extracellular matrix (ECM) in mesan-
gial area. The accumulated ECM includes type IV collagen
[(IV)eollagen], laminin, fibronectin and type I collagen [(I)colla-
gen] [1 We reported that AGEs bound to a specific receptor on
mesangial cells and increased the synthesis of ECM. The AGEs
responses were determined at the transcriptional level, however,
factors controlling gene expression have not been determined.
One report about direct interaction between genes and AGEs
indicated a direct structural modification of DNA as a result of
complex formation [81. Recent reports have also show that AGEs
activate transcription factor NF-KB, which may stimulate the
transcriptional activation of cytokines and cell adherence mole-
cules [91. These findings suggest a mechanism for the biological
effects of oxidant stress; however, the transcriptional regulation of
gene expression mediated by the other mechanism has not been
elucidated. Since (IV)collagen is a major component of the
expanded ECM in diabetic glomerulopathy, it is important to
clarify the mechanisms by which the (IV)collagen is regulated at
the transcriptional level in pathologic conditions. In this paper we
focused on the effect of AGEs on the transcription of the
(IV)collagen gene. We found that AGEs promote the transcrip-
tion of the (IV)eollagen gene by modulating several transcription
factors. Recent reports suggest a phenotypic change of mesangial
cells in glomerular injuries, reflecting an increase of smooth
muscle a-actin (SMA) expression [10]. These phenotypic changes
were also found in several human diseases including IgA nephrop-
athy, diabetic nephropathy, membranoproliferative glomerulone-
phritis and focal glomerulosclerosis. However, the causal mecha-
nisms are still unknown. We also showed that the SMA gene was
up-regulated transcriptionally as a consequence of AGEs stimu-
lation.
Methods
Cell culture
A glomerular mesangial cell line was established from glomer-
uli isolated from normal 4-week-old mice (C57BL/6J x SJL/J) and
was identified according to a method described previously [3, 111.
We used phenotypically stable cells, passages 14 to 24, maintained
in B medium and 20% fetal bovine serum (Irvine Scientific) and
passagcd weekly with trypsin-EDTA.
Preparation of ligands
AGE-bovine serum albumin (BSA) was prepared by the regular
methods as described previously [3, 12, 13]. Unmodified BSA was
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incubated under the same conditions without glucose 6-phosphate
for controls. Protein concentration was determined by the Brad-
ford method using BSA as a standard. All AGE-protein specific
fluorescence determinations were performed by measuring emis-
sion at 440 nm upon excitation at 370 nm using a fluorescence
spectrometer (Hitachi). AGE content was estimated by fluores-
cence intensity at a protein concentration of 1 mg/mi. AGE-BSA
contained 57.3 AGE units per mg of protein, and unmodified BSA
contained 2.63 AGE units per mg of protein.
RNA isolation
Mesangial cells (1.2 >< 106) were plated in medium/20% fetal
bovine serum in 100 mm dishes coated with AGE-BSA or control
BSA at 25 sg/cm2 for 72 hours. Preliminary experiments revealed
that the AGE-induced effect was not detectable up to 48 hours of
incubation with AGEs. Therefore, subsequent experiments were
done after 72 hours of exposure. The cells were washed with PBS,
and total RNA was extracted by the guanidine isothiocyanate
method [14].
RNA probe preparation
The eDNA (p1234) cloned in pGEM2 vector (Promega) codes
for a portion of the major triple helical region plus the globular
domain (NC]) of the mouse c1 (IV)collagen chain [15]. pOMIOl,
pSAHE1, and pGMGAEHI code for mouse a2 type I procolla-
gen, mouse SMA, and mouse glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH), respectively [16, 17]. The eDNA insert [3.5
kilobase pairs (kbp]] for murine A1-p145 [MSW: (IV)collagen
promoter binding protein] was subcloned into EcoRI site of
Bluescript SK (-) (Stratagene) [18]. Orientation of the insert was
determined by restriction enzyme digests.
Hybridization probes were prepared by linearizing the con-
structs with ApaI for pGM1O1, PvuIJ for p1234, HindIII for
pSAHE1, EcoRI for pGMGAEHI and PvuIl for MSW. Before
transcription in vitro, the linearized pGMIOI was treated with
Kienow DNA polymerase (Promega) to convert the 3' protruding
ends to blunt termini. The in vitro transcription reaction contained
1 g of template DNA, [32P]UTP (NEB), and the SP6 or T7 RNA
polymerase (Promega) as described [17, 19]. The 1 kilobase (kb)
ladder or 100 base pair (bp) ladder, which was labeled with
[32P]dCTP by the replacement synthesis method with T4 DNA
polymerase (BRL/Life Technologies), was used as a control size
marker. All restriction enzymes were purchased from Wako Pure
Chemical Industries, Ltd.
Solution hybridization RJ'Jase protection assay
The RNA probe (4 >< iO cpm) and 1 jg of total RNA were
hybridized overnight at 45°C. RNase A (40 g/ml) was added to
each tube and incubated for one hour at 30°C. RNasc-resistant
fragments were analyzed by 3.5% or 7% poiyaciylamide/8 M urea
gel electrophoresis and autoradiography [17]. The protected band
of each RNA probe had the same size as the coding sequence for
specific mRNA providing evidence for their specificity.
DNA transfecrion
The a] (IV)collagen promoter-enhancer-CAT construct (p56)
was described previously [20]. The construct SMP-1 contains 1074
bp of the proximal 5'-flanking region plus 43 bp 5'-untranslated
region of the SMA gene that is cloned into the Sall-BarnHl site of
the SV4O enhancer containing CAT vector, pBLCAT3 [21].
Four >< iO cells were plated on a 60 mm dish for 90 minutes and
transfected with plasmid DNA using the standard calcium phos-
phate coprecipitation technique [22]. Typically, 15 jig of CAT
reporter plasmid and 4 jig of pSV-J3-galactosidase (Promega)
(internal control for transfection efficiency) were used. The cells
were exposed to the precipitates for four hours, washed and B
medium containing 20% FBS was again added. After 48 hours,
the cell layers were harvested and assayed for CAT and f3-galac-
tosidase activity [23, 24]. CAT (Pharmacia) or 13-galactosidase
(Promega) were used as standards. The pSVOCAT and pSV2CAT
were used for negative and positive controls, respectively [22]. A
correction factor for differences in transfection efficiency was
obtained by normalizing CAT activity to the J3-galactosidase
activity and subtracting the background level, as determined by
transfection with pSVOCAT. The final level was expressed as
relative CAT activity.
DNA inethylation pattern
High molecular weight cellular DNA was prepared from each
cell line after 72 hours of incubation with AGE-BSA or control
BSA, by the procedure of Britten, Graham and Neufeld [25].
Aliquots (15 jig) of DNA were digested with HpaII or MspI
restriction endonucleases (5 units/jig of DNA) for 18 hours at
37°C. DNA samples were electrophoresed on a 1% agarose gel
and transferred to Nytran by the Southern method [26]. Specific
band patterns were detected by specific probes for the promoter
and enhancer elements of the al (IV)collagen gene (XhoI frag-
ment of PS6) [20, 27], the a2 (I)collagen gene (XhoI fragment of
pGMIO1) [28], or promoter elements of the SMA gene (HindIII-
BamHI fragment of the 5' end SMP-1) [29]. These fragments
were labeled by the random primer method [30].
Preparation of nuclear extract
Subconfluent cells incubated with AGE-BSA or control BSA
for 72 hours were collected at 4°C and resuspended in hypotonic
buffer (10 mM HEPES, pH7.9/1.5 mlvi MgCI2/10 ms KCI/0.2 mM
phenylmethylsulfonyl fluoride (PMSF)/0.5 mvi dithiothreitol
(DTT)) and allowed to swell on ice 10 minutes. The cells were
homogenized in a Dounce homogenizer. The nuclei then were
pelleted at 4°C and resuspended in low-salt buffer (20 mi
HEPES, pH 7.9, 25% glycerol/l.5 ms MgCl2/20 mivi KCI/0.2 mM
EDTA/0.2 mivi PMSF/0.2 ms'i DTT). An equal volume of high-salt
buffer (20 mM HEPES, pH 7.9/25% glycerol/I .5 mivi MgCl2/1.2 M
KCI/0.2 mivi EDTA/0.2 mrvi PMSF/0.2 msi DTT) was added. The
nuclei were centrifuged for 30 minutes at 25,000 X g. The nuclear
extracts were dialyzed against 200 ml dialysis buffer (20 mivi
HEPES, pH 7.9/20% glycerol/lOU mivi KCI/0.2 ms EDTA/0.2 mM
PMSF/0.5 mivi DTT) overnight [31]. Protein concentration of
nuclear extract was determined by the Bradford assay [32].
Gel mobility-shift assay
The following three oligonucleotidc pairs were synthesized
(Kuraho). CIV- I (5'-TTCCTCCCCT TGGAGGAGCG CCGC-
CCG-3') contains the binding site of Al-p 145 from the promoter
of a] (IV)collagen gene. FT-A (5'-ACTCCTTATC TCTGATG-
GCG-3') and FT-B (5'-CAGTGTCATA ACAGCCAGGG-3')
included a site for nuclear factor binding from the (IV)collagen
enhancer region. They were end-labeled with [32P]ATP by T4
polynucleotide kinase and purified by resin column filtration
(Clontech). These oligonucleotides were incubated with 4 jig of
uI(IV)coIIagen SMA GAPOH
1 2 3 4 5 6
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nuclear extracts and 1.5 pg of poiy (dl-dC) in a final volume of 10
tl containing 10 mM Tris-HC1 (pH 7.5), 50 mivi NaCI, 0.5 mM
DTT, 10% glycerol, and 0.05% nonidet P-40. Binding was allowed
to proceed at room temperature for 20 minutes. The samples were
analyzed by a 5% non-denaturing polyacrylamide gel electro-
phoresis in a low ionic strength buffer and autoradiography [33].
In gel supershift assay, 1.0 tl of appropriate diluted anti-MSW
antibody or irrelevant antibody were added to the 10 l of a
standard gel shift reaction, after the addition of the 32P-labeled
oligonucleotide [18]. For the competition assay, Spi consensus
oligonucleotide (5'-ATTCGATCGG GGCGGGGCGA GC-3')
(Santa Cruz Biotechnology, Inc.) was used.
Statistical analysis
Data were expressed as the mean SE and evaluated with
analysis of non-parametric test (Mann-Whitney analysis).
Results
Fig. 1. Effect of AGEs on mRNA synthesis in
mesangial cells. Levels of mRNAs coding for
ECM were analyzed by solution hybridization
protection assay. Cells were exposed to control
BSA (lanes 1, 3, 5) or to AGE-BSA (lanes 2, 4,
6). al (IV)collagen (lanes 1, 2), SMA (lanes 3,
4), GAPDH (lanes 5, 6). There are many extra
small bands in lanes 3 and 4. These small bands
in the tRNA control lane can be detected
without total RNA (data not shown).
mRNA levels after stimulation with AGEs
The mRNAs for (IV)collagen, SMA and GAPDH were easily
detectable in mesangial cells (Fig. 1), whereas (I)collagen mRNA
was not detectable (data not shown). The mRNA levels for
(IV)collagen and SMA were significantly increased after incubat-
ing cells with AGE-BSA for three days, compared with BSA
alone. This difference was not detectable at day 1 and disappeared
at seven days (data not shown). A GAPDH mRNA level was
equivalent in cells plated on control and AGE-BSA.
Methylation state and regulation of transcription
To elucidate the mechanisms of transcriptional change, we
examined the DNA methylation state in the transcriptional regu-
latory elements (cis-elements) of these genes with a Southern blot
analysis. The methyl-sensitive restriction enzyme, HpalI, did not
cut CCGG sites if the internal cytosine was methylated, yet its
isoschizomer, Mspl, did cut the internal cytosine methylated
CCGG sites. Neither enzyme cut if the external cytosine was
methylated [31•
The methylation pattern of the promoter elements of the SMA
genes was examined in AGE-treated and control cells (Fig. 2A).
Control cells showed specific bands of 10 and 1.3 kbp with HpaIl
digestion and 4.3 and 1.3 kbp bands with MpI digestion, which
indicated that the promoter elements of the SMA gene were
partially methylated. AGE-treated cells showed the same band
patterns with HpaII digests as the control cells. However, the Mpl
digestion exhibited specific hands of 4.3, 1.6 and 1.3 kbp. The
presence of a 1.6 kbp band indicated that AGEs induced de-
Fig. 2. Methylation pattern of the regulatoiy elements of the (I)collagen,
(JV)collagen and SMA genes with AGEs stimulation. DNA was isolated
from both AGEs stimulated mesangial cells and control cells. DNA was
digested with HpaII or Mspl, electrophoresed, and blot-hybridized with a
probe to the regulatory elements of the (I)collagen gene, the (IV)collagen
gene or the SMA gene as described in the Methods section. The size of the
fragments is shown in kilobases. Mesangial cells stimulated by AGEs are
represented by lanes 3 and 4, whereas control cells are represented by
lanes 1 and 2. Lanes 1 and 3 were digested with HpaII; lanes 2 and 4 were
digested with MspI. A. The promoter element of the SMA gene was used
as a hybridization probe. The presence of specific bands of 10 and 1.3 kbp
with HpaII digestion, and 4.3 and 1.3 kbp bands with MspI digestion, which
indicated the gene was partially methylated. The presence of 1.6 kbp band
in lane 4 indicated that AGEs induced demethylation of the external
cytosine of CCGG in the promoter element. B. The promoter and
enhancer elements of the (IV)collagcn gene were used as a hybridization
probe. The presence of 1.8 kbp and 0.3 kbp band in all lanes indicated that
the internal cytosine of CCGG was unmethylated. The existence of 0.8 kbp
band in lane 4 indicated that AGEs induced demethylation. C. The
promoter and enhancer element of the a2 (I)collagen gene was used as a
hybridization probe. The presence of 3.5 kbp and 0.4 kbp bands indicated
the gene was methylated in both cells. The presence of 1.6 kbp band in
lane 4 also indicated that AGEs induced demethylation.
methylation of the external cytosine of CCGG in the promoter
element.
The methylation patterns of the al (IV)collagen promoter and
enhancer elements were evaluated with MspI and HpaII (Fig. 2B)
[35]. The gene was unmethylated in both AGEs treated and
a
 
Cr
 
.
_
 
-
S 
a
 
-
.
 
C.
) 
0 
w
 
C,
 
Ii 4 5 5ass as s
•r a
Jehara et al: Transcriptional control by advanced glycation 1169
T
Type IV collagen Smooth muscle a actin
B
B
Fig. 3. Effect ofAGEs on transcriptional activity. Transient transfection of
mouse mesangial cells was performed as described in the Methods section,
and chloramphenicol acetyltransferase (CAT) activity was determined 48
hours after transfection. The values shown are percentages of total
chloramphenicol converted to acetylated derivatives. The pSV0CAT and
pSV2CAT were used for negative and positive controls. This percentage
was calculated from data obtained by counting scintillation cocktail
including extracted labeled product and was corrected by transfection
efficiency and background level. The results shown are the means SE of
four separate experiments. Symbols are: (U) AGEs treated; () control.
control cells, in agreement with its high level of expression. The
MspI digests showed a 1.8 kbp band as well as a 0.3 kbp band in
these cells, indicating that the external cytosine was methylated.
The existence of 0.8 kbp band with the Mspl digestion indicated
that AGEs induced demethylation.
The methylation pattern of promoter/enhancer elements of the
cr2 (I)collagen gene was determined in AGE-treated and control
cells (Fig. 2C). As judged by the presence of 3.5 kbp and 0.4 kbp
bands in the MspI I digests, the gene was methylated in both cells,
thus the cr2 (I)collagen gene was not expressed. The presence of
1.6 kbp band, in the MspI digests of AGE-treated cells also
indicated partial demethylation in promoter/enhancer elements of
the cr2 (I)collagen gene.
Trans-acting elements
The role of trans-acting elements in the regulation of transcrip-
tion was investigated by transiently transfecting cells with fusion
constructs containing the promoter/enhancer/chloramphenicol
acetyltransferase (CAT) for each gene. Correction for transfec-
tion efficiency was accomplished by cotransfection with pSV-13-
galactosidase as an internal control. pSVOCAT and pSV2CAT
were used as negative (0%) and positive (100%) controls, respec-
tively. AGEs treated cells or control cells were transfected with
target constructs by the calcium-phosphate method.
Transcriptional activity of the promoter of the SMA gene was
analyzed by using the construct, SMP-1, which contained the SMA
promoter, the SV4O enhancer and the CAT reporter gene (Fig. 3).
CAT activity was increased 37-fold in AGE-treated cells com-
pared with control cells, indicating that AGEs significantly stim-
ulated promoter activities of the SMA gene. There was a corre-
lation between the relative CAT activity and the levels of
endogenous smooth muscle cr-actin mRNA expression.
A construct P56, containing the promoter/enhancer of the cr1
F
Fig. 4. Binding of nuclear factors to the CIV-1 oligonucleotides. Gel mobil-
ity shift assay of the (IV)collagen promoter with mouse mesangial cell
nuclear extracts. The CIV-1 oligonucleotide from the promoter region was
radioactively labeled and was incubated with nuclear extracts isolated
from mouse mesangial cells (lanes I to 8). In lanes 2, 4, 6 and 8, the
nuclear extracts were isolated from AGEs stimulated cells. Lanes 1, 3, 5
and 7, the nuclear extracts were isolated from control cells. Lanes 1 and 2,
no competitor; lanes 3 and 4, reactions contained 100-fold molar excess of
unlabeled oligonucleotides. Lanes 5 and 6, reactions contained 100-fold
molar excess of SP1 consensus motif oligonucleotides. Lanes 7 and 8,
reactions contained anti-MSW antibody. Super shifted band was detected
in lane 7.
(IV)collagen gene and the CAT gene, was used for evaluation of
transcriptional activity of (IV)collagen. AGEs induced a 16-fold
increase in CAT activity compared with control, demonstrating
that AGEs enhanced transcriptional activity of the cr1 (IV)colla-
gen gene (Fig. 3).
These data suggest that increased mRNA levels for SMA and
(IV)collagen by AGEs are due to the increase in promoter activity
of their genes. The promoter activity of SMA gene is regulated by
both the methylation state of the enhancer and/or promoter
elements and trans-acting elements. The promoter activity of cr1
(IV)collagen gene is mainly regulated by trans-acting elements.
Regulation of transcription factors for the cr1 (I V..1 collagen gene by
A GEs
To further investigate the effect of AGEs on the transcriptional
regulation of the cr1 (lV)collagen gene, DNA binding proteins for
the promoter and enhancer elements of the cr1 (IV)collagen gene
were examined by a gel mobility-shift assay.
Figure 4 shows the gel mobility shift of the CIV-1 site [a part of
promoter sequence of the (IV)collagen genes] when incubated
with nuclear extracts prepared from mesangial cells treated with
AGE-BSA or with control BSA. The migration of the labeled
CIV-1 site indicated an interaction between proteins and DNA.
The intensity of the shifted hand was dependent on the amounts
of nuclear extracts (0.5, 1.5, 4.5 rg) (data not shown). The shifted
band competed with the excess amounts of the unlabeled CIV-1
site DNA. Since the CIV-i site contained a consensus sequence
for Spi binding, the gel shift assay was performed with the Spi
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Fig. 5. Effect of AGEs on MSW mRNA production. mRNAs coding for
MSW were measured by solution hybridization protection assay. Cells
were exposed to control BSA (lane 1) or to AGE-BSA (lane 2). The result
of densitometric analysis was 12.8 (lane 1) and 0.8 (lane 2). Densitometry
readings were normalized for equivalent amounts of GAPDH RNA per
sample to confirm equal loading of RNA.
binding sequence as an unlabeled excess competitor to rule out an
involvement of Spi. The shifted band then did not compete with
the Spi consensus motif (Fig. 4). Control nuclear extracts showed
one shifted band of the CIV-1 site. The CIV-1 site contained a
binding sequence for MSW [(IV)collagen promoter binding pro-
tein]. Therefore, we performed gel supershift assays with anti-
MSW antibody added to the standard gel shift reaction, and a
supershifted band was detected in the control lane. On the other
hand, AGE induced a differently sized shifted band that was not
supershifted by adding anti-MSW antibody. Next the MSW
mRNA levels were examined in these cells. Like the data from gel
shift assays, the MSW mRNA levels were significantly decreased
in AGE-treated cells (1/15.8-fold; Fig. 5). The results suggest that
AGE decreased MSW and induced a novel DNA-binding protein
of the CIV-1 site.
The labeled FT-A and FT-B sites from the enhancer region of
the cxl (IV)collagen gene were also tested for their activity of
nuclear factor binding. There was no difference between AGE-
treatment and control (data not shown). These experimental
results indicate that AGEs modulate some nuclear factors that
bind to the promoter elements of the (IV)collagen gene.
Discussion
Significant advances in the understanding of advanced glycation
end products (AGEs) for development of diabetic complications
have been made in the past few years [1, 2]. Especially in diabetic
nephropathy, AGEs accumulate in the glomeruli in nonobese
diabetic mice [36] and diabetic humans [371. The prescribed
AGEs increased the glomerular extracellular matrix in the normal
mouse [381. Our previous report showed that AGEs increased
synthesis of extracellular matrix (ECM) in mesangial cells through
a specific receptor [3]. In this study, we examined the effect of
AGEs on the transcriptional regulation for the (IV)collagen gene.
Our findings suggest that this effect was mediated through multi-
ple steps, including the increased nuclear factor binding of the
promoter of the (IV)collagen gene accompanying with demethy-
lation of these elements. These regulatory mechanisms induced by
AGEs appear to be associated with the development of glomer-
uloscierosis. Our study shows that AGEs stimulate the synthesis of
smooth muscle cx actin (SMA), which is a marker for phenotypic
change in the course of developing glomerulosclerosis [10]. These
findings may provide new information about the pathogenic role
of AGEs in the development of diabetic nephropathy.
The present study showed that CCGG in regulatory elements
for the (I)collagen was highly methylated in associated with low
gene expression in both control and AGE-treated cells. On the
contrary, regulatory elements for the (IV)collagen gene and the
SMA gene were not methylated in control and AGE-treated cells,
which was consistent with high levels of gene expression. We also
found that AGEs induced a demethylation in external cytosine of
CCGG in all genes. However, the gene expression was not only
regulated by demethylation in external cytosine, since AGEs
induced demethylation of the regulatory element of the (l)colla-
gen gene without mRNA expression. These findings were corrob-
orated by evidence that the level of expression of the (I)collagen
gene was independent of methylation [39]. A recent report
showed that free radical adducts play a role in DNA cytosine
demethylation [40], suggesting that demethylation of AGEs was
mediated by formation of free radicals. This phenomenon sug-
gests the possibility that AGEs may activate several genes and
affect the differentiation state of the cells. On the other hand,
AGEs directly form AGE-DNA and increase mutations [8]. These
unexpected activities could account for the development of fetal
abnormalities resulting from diabetic pregnancies or age-related
cancers.
Transient transfection assays revealed that AGEs enhance
transcriptional activity of both the (IV)collagen gene and the
SMA gene, indicating the important role of trans-acting factors.
The (IV)collagen gene consists of cxl chain and a2 chain genes in
a head-to-head manner and regulated by 130 bp hi-directional
promoter between the two genes and an enhancer in the first
intron of the cxl (IV)collagen gene [27]. Recently a protein factor,
MSW, which binds to the promoter, was cloned and sequenced
[18]. MSW contains several domains homologous the smaller
subunits of replication factor complex, Al, and appears to iden-
tical to a larger subunit, A145, of Al. Therefore MSW could play
a role in both transcription and replication. This paper shows that
AGEs induce some nuclear factor binding of the promoter of the
(IV)collagen genes. The data from supershift assays using anti-
MSW antibody shows that the promoter binding protein increased
by AGEs is different from MSW. On the contrary, MSW itself is
decreased after treatment with AGEs. The MSW-binding oligo-
nucleotide (CIV-1) includes the Spl consensus sequences. The
increased DNA binding protein is not Spl, since it does not
compete with excess Spi consensus sequences. No other known
transcription factors binding this oligonucleotide were identified
through a search of the Transcription Factor Database (version 7,
National Center of Biological Information). These findings sug-
gest that both down-regulation of MSW and up-regulation of
novel promoter binding proteins are important for augmenting
(IV)collagen gene expression by AGEs.
SMA is the most abundant protein in differentiated smooth
muscle cells (SMC) and is one of the earliest proteins expressed
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during the differentiation of SMC. Although SMA is expressed by
a variety of mesoderm-derived cells during development, its
expression in differentiated cells is limited to SMC and SMC-
related cells. Thus we can use SMA as a phenotypic marker of
mesangial cells [41]. The mechanism of the gene expression of
SMA is partially revealed. In rat vascular smooth muscle cells,
arginine vasopressin induced the gene expression through the
CArG elements in the promoter of the SMA gene [42]. In
mesangial injuries, the gene expression of SMA was increased in
association with the mesangial cell phenotypic change. AGE
stimulation also increased the gene expression of SMA as a
consequence of transcriptional activation. It is important to find
the transcription factors and the crucial regulatory elements
involved in the SMA gene expression, and to identify the factor
determining the phenotypic change.
An epidemiological study showed that only 30 to 40% of
diabetic patients develop diabetic nephropathy. Recent animal
and human data suggest that the predisposition, or resistance, to
the development of glomerulosclerosis was genetically deter-
mined [43]. However, long-term hyperglycemia and elevated
AGE levels were strongly implicated in the initiation and accel-
eration of multiple organ injuries in diabetes, including vascula-
ture, kidneys, and nerves. This hypothesis is supported by the
following facts: a recent sensitive immunohistochemical technique
revealed that AGEs accumulated in the circulation and organ
tissues of diabetic patients or aged people [44]; treatment for eight
months with aminoguanidine, an inhibitor of AGE formation,
exhibited inhibitory effects on glomerular lesions and retardation
of albuminuria in diabetic model rats [45]; and there were
scavenger systems for AGEs in several organs [46]. In this study,
we clarified some unique regulatory mechanisms of AGEs for a
pathological role in diabetic glomerulosclerosis.
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muscle a-actin; BSA, bovine serum albumin; PBS, phosphate buffered
saline; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; kbp, kilo-
base pairs; MSW, mouse southwestern; bp, base pair; CAT, chloramphen-
icol acetyltransferase; PMSF, phenylmethylsulfonyl fluoride; DTF, dithio-
threitol.
Reprint requests to Toshio Doi, M.D., Division of Amficial Kidneys,
Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan.
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